Trial Profile
Asthma in the Elderly: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study of the Effect of Montelukast
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 04 Oct 2016 Status changed from active, no longer recruiting to completed.
- 09 May 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Dec 2015 New trial record